Evidence map›Paper›PMID 32862257›Full record

ArticleCellular and molecular neurobiology2021

The Effects of Proton Pump Inhibitors (Pantoprazole) on Pentylenetetrazole-Induced Epileptic Seizures in Rats and Neurotoxicity in the SH-SY5Y Human Neuroblastoma Cell Line.

Ahmet Sevki Taskiran, Mustafa Ergul, Handan Gunes, Aysegul Ozturk, Bilal Sahin, Ercan Ozdemir

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Anticancer activity of lycopene in HT-29 colon cancer cell line.Medical oncology (Northwood, London, England) · 2023
    Article
  12. Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ahmet Sevki TaskiranDepartment of Physiology, Sivas Cumhuriyet University School of Medicine, 58140, Sivas, Turkey. ahmettaskiran@cumhuriyet.edu.tr.ORCID http://orcid.org/0000-0002-5810-8415
Mustafa ErgulDepartment of Biochemistry, Sivas Cumhuriyet University School of Pharmacy, Sivas, Turkey.
Handan GunesDepartment of Physiology, Sivas Cumhuriyet University School of Medicine, 58140, Sivas, Turkey.
Aysegul OzturkDepartment of Physiology, Sivas Cumhuriyet University School of Medicine, 58140, Sivas, Turkey.
Bilal SahinDepartment of Physiology, Sivas Cumhuriyet University School of Medicine, 58140, Sivas, Turkey.
Ercan OzdemirDepartment of Physiology, Sivas Cumhuriyet University School of Medicine, 58140, Sivas, Turkey.
Sivas Cumhuriyet Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have shown that proton pump inhibitors have positive effects on the nervous system. However, its effect on epileptic seizure and neuronal damage are still unclear. In this study, it was aimed to investigate the effect of pantoprazole on pentylenetetrazole-induced epileptic seizures in rats and neurotoxicity in the SH-SY5Y cell line. Animals were divided into three groups: control, saline (1 mL/kg serum physiologic), and pantoprazole (10 mg/kg). Pentylenetetrazole (45 mg/kg) was given to induce a seizure and a passive avoidance test trial was carried out to evaluate memory function. 8-hydroxy-2'-deoxyguanosine (8-OHdG), caspase-3, and brain-derived neurotrophic factor (BDNF) levels were measured in the brain by commercial kits. SH-SY5Y cells were treated with saline or pantoprazole for one hour, and then pentylenetetrazole (30 µm) was added to the medium to induce neurotoxicity. After 24 h, cell viability, total antioxidant, total oxidant status, and apoptosis were measured in SH-SY5Y cells. It was found that pantoprazole treatment postponed epileptic seizure onset, protected memory, reduced 8-OHdG, caspase-3, and also increased BDNF in the brain. In addition, it blocked pentylenetetrazole toxicity, apoptosis, increased antioxidant, and decreased oxidant status in SH-SY5Y cells. Pantoprazole significantly improved seizure, oxidative stress, and apoptosis. Thus, pantoprazole could be used as a supportive therapeutic agent in epilepsy.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAnimalsAntioxidantsApoptosisBrainBrain-Derived Neurotrophic FactorCaspase 3Cell Line, TumorCell SurvivalHumansMaleNeuroblastomaNeurotoxinsOxidantsOxidative StressPantoprazole8-Hydroxy-2'-DeoxyguanosineAntioxidantsBrain-Derived Neurotrophic FactorCaspase 3NeurotoxinsOxidantsPantoprazolePentylenetetrazoleProton Pump InhibitorsEpilepsyPantoprazolePentylenetetrazoleRatsSH-SY5Y

Identifiers

PMID32862257
PMCPMC11448680
OpenAlexW3082669816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.